Our previous studies have reported that miR-124 inhibited CDK4 expression in breast cancer cells, therefore, we testes whether MALAT1 inverted the inhibitory effect of miR-124 on CDK4 expression. This evidence concerns the gene CDK4 and breast carcinoma.